Skip to main content

Crown Bioscience 即將舉辦創新虛擬 AACR 2020 會議和貿易展覽會

Written by Customer Service on . Posted in Public Companies.

聖地牙哥, June 19, 2020 (GLOBE NEWSWIRE) — Crown Bioscience 今天宣佈即將舉行創新的 AACR 2020 會議和貿易展覽會。於 6 月 22 日至 25 日舉行的虛擬活動將涵蓋主要科學會議的所有功能，並安排主題講者、CrownBio 的 AACR 2020 海報及貿易展位。
為與第二屆 AACR 虛擬年會配合，此獨特論壇將展示 CrownBio 出版 13 份內部和協作式 AACR 2020 海報，主題包括一系列臨床前腫瘤學，而免疫腫瘤學主題則包括腫瘤類器官和類器官工程、造影同基因和腫瘤同種異體移植，以及創新個人化藥物標靶模型，更邀請海報作者為所有代表解答提問。活動免費參加，但需預先在 CrownBio.com/AACR20上登記。Keynote Theater 的亮點包括由 CrownBio 首席科學總監 Henry Li 博士發表關於採用患者衍生類器官 (PDO) 加速藥物發現的演講，而其他演講將討論生物標記物發現、將 虛擬篩選 應用到體外藥物發現，以及免疫療法毒理學評估平台。CrownBio 市場營銷執行總監 Gavin Cooper 說：「即使我們在全球各地面臨挑戰，但我們仍致力推動科學討論和藥物發現。我們創新的活動體驗旨在實時提供我們所有資源、海報和科學團隊，盡量充分模仿實地會議帶來的體驗。」活動還設有一個科學休息室，以便參與者向科究人員發問和進行實時討論。貿易展位可提供一系列廣泛的 CrownBio 資源，展示大量產品和服務，包括類器官、生物標記物發現、生物資訊學和患者衍生異種移植 (PDX) 模型。活動現己接受免費登記：CrownBio.com/AACR20。關於 Crown Bioscience Inc.Crown Bioscience 是一家 JSR 生命科學公司，是一家全球藥物研發和開發服務公司，提供轉化平台以推進腫瘤學、炎症和代謝疾病研究。憑著廣泛的相關模型和預測工具組合，Crown Bioscience 使客戶能夠提供優質的臨床候選產品。如欲了解更多詳情，請瀏覽：https://www.crownbio.comhttps://www.jsrlifesciences.com傳媒查詢：Crown BioscienceJody Barbeaupr@crownbio.com本新聞發佈隨附的相片載於 https://www.globenewswire.com/NewsRoom/AttachmentNg/2e34cb8b-be2b-4be4-b596-1e33d74cd138

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.